These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10944125)

  • 1. High-time chemotherapy or high time for low dose.
    Kamen BA; Rubin E; Aisner J; Glatstein E
    J Clin Oncol; 2000 Aug; 18(16):2935-7. PubMed ID: 10944125
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of cancer with high-dose chemotherapy and autologous stem cell transplantation].
    Geisler CH; Daugaard KG; Dickmeiss E; Ifversen M; Knudsen LM
    Ugeskr Laeger; 2003 Dec; 165(50):4846-9. PubMed ID: 14716902
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell cycle dependent response and combined treatment of tumor.
    Terasima T; Ohara H; Miyamoto T; Watanabe M; Takabe Y; Watanabe I
    Jpn J Antibiot; 1977 Dec; 30 Suppl():49-56. PubMed ID: 77340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High-dose chemotherapy for tumor treatment: the end of the beginning ?].
    Bay JO; Blay JY
    Bull Cancer; 2001 Sep; 88(9):821. PubMed ID: 11604351
    [No Abstract]   [Full Text] [Related]  

  • 5. NCCN: High-dose chemotherapy. Applications of high-dose chemotherapy with bone marrow/stem cell support in solid tumors.
    Vaughan WP
    Cancer Control; 2001; 8(6 Suppl 2):50-2. PubMed ID: 11760558
    [No Abstract]   [Full Text] [Related]  

  • 6. Where next with stem-cell-supported high-dose therapy for breast cancer?
    Bergh J
    Lancet; 2000 Mar; 355(9208):944-5. PubMed ID: 10768427
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose chemotherapy and stem cell rescue for high-risk Ewing's family of tumors.
    Rosenthal J; Pawlowska AB
    Expert Rev Anticancer Ther; 2011 Feb; 11(2):251-62. PubMed ID: 21342043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are there still reasons to believe that high-dose chemotherapy has a role in breast cancer management?
    Castagna L; Martino M
    Bone Marrow Transplant; 2013 Feb; 48(2):305. PubMed ID: 22750999
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of high-dose chemotherapy and autologous stem cell support in treatment of breast cancer.
    Myers SE; Williams SF
    Hematol Oncol Clin North Am; 1993 Jun; 7(3):631-45. PubMed ID: 8102137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of dose-response relationships in the setting of high-dose ifosfamide, carboplatin, and etoposide and autologous hematopoietic stem cell transplantation: implications for the treatment of patients with advanced breast cancer.
    Perkins JB; Effenbein GJ; Fields KK
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):42-6. PubMed ID: 8677448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dose intensity in cancer chemotherapy (including high dose chemotherapy)].
    Ariyoshi Y; Ogawa M
    Gan To Kagaku Ryoho; 1994 Dec; 21(16):2699-707. PubMed ID: 7993104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-dose factors in chemotherapy: expanding the concept of dose-intensity.
    Dembo AJ
    J Clin Oncol; 1987 May; 5(5):694-6. PubMed ID: 3572462
    [No Abstract]   [Full Text] [Related]  

  • 13. Introduction: dose-intensive therapy for adult malignancies.
    Weiss RB
    Semin Oncol; 1999 Feb; 26(1):1-5. PubMed ID: 10073557
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of cell kinetics in cancer chemotherapy.
    Valeriote FA; Edelstein MB
    Semin Oncol; 1977 Jun; 4(2):217-26. PubMed ID: 327554
    [No Abstract]   [Full Text] [Related]  

  • 15. High dose therapy and autologous hematopoietic stem cell transplantation in septuagenarians with non-Hodgkin lymphoma: Feasible, but for which patients?
    Wildes TM; Cashen A
    J Geriatr Oncol; 2015 Sep; 6(5):344-5. PubMed ID: 26272671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose metronomic chemotherapy: myth or truth?
    Baruchel S; Stempak D
    Onkologie; 2006 Jul; 29(7):305-7. PubMed ID: 16874013
    [No Abstract]   [Full Text] [Related]  

  • 17. Additional transplantation of ex vivo generated megakaryocytic cells after high-dose chemotherapy.
    Scheding S; Bergmannn M; Rathke G; Vogel W; Brugger W; Kanz L
    Haematologica; 2004 May; 89(5):630-1. PubMed ID: 15136238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Principle and foundations of high dose therapy with stem cell transplantation].
    Haas R; Hohaus S; Murea S; Schmid H; Wallwiener D; Bastert G; Wannenmacher M; Hunstein W
    Zentralbl Gynakol; 1996; 118(10):575-7. PubMed ID: 8999714
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement.
    Rodenhuis S; Richel DJ; van der Wall E; Schornagel JH; Baars JW; Koning CC; Peterse JL; Borger JH; Nooijen WJ; Bakx R; Dalesio O; Rutgers E
    Lancet; 1998 Aug; 352(9127):515-21. PubMed ID: 9716055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of highly malignant non-Hodgkin lymphoma with high-dose chemotherapy and stem cell transplantation].
    Schmitz N
    Praxis (Bern 1994); 1998 Jun; 87(25-26):863-8. PubMed ID: 9702088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.